Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Technology NAV Declines, Appealing VCT Status Withdrawal

Tue, 27th May 2014 12:47

LONDON (Alliance News) - Oxford Technology VCT PLC saw its net asset value per share decline in the year to end-February, and said it was appealing the withdrawal of its venture capital trust status.

The trust posted a net asset value per share of 65 pence per share, down from 74 pence in the previous year.

It posted a pretax profit of GBP36,000, down from GBP2.7 million in the previous year. This was due to seeing no income during the year, and lower unrealised gains on the fair value of its investments.

In March the company's status as a venture capital trust was withdrawn by HM Revenue and Customs, which it has subsequently appealed.

This was a result of the company's investment in Scancell Holdings PLC; the HMRC's rules state that when a company makes a new investment the value of its holding has to be valued at the most recent price paid for the shares. No company is allowed to account for more than 15% of the trusts portfolio, however due to the sharp increase in Scancell's share value this rule was breached.

The company realised this had happened in October, and informed HMRC of the breach, it said.

Oxford Technology said that HMRC had taken "a hard line" over the rule, despite "the fact that this technical rule had been breached no harm had been done to anyone."

The trust reiterated that shareholders should seek their own financial advice to ascertain the implications of it losing its VCT approval, and take appropriate action. Oxford Technology said it was continued to operate as a VCT, but that if its appeal was unsuccessful would work under the structure of an investment trust.

Shares in Oxford Technology Venture Capital Trust last traded up 22.2% at 55.00 pence.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2022 13:10

Scancell opens recruitment for cancer therapy trial

(Sharecast News) - Immunotherapy developer Scancell announced on Monday that its phase 1 and 2 clinical trial with 'Modi-1' is open for recruitment.

Read more
11 Apr 2022 12:02

LONDON MARKET MIDDAY: CAC moves green for Macron, FTSE 100 lags

(Alliance News) - Stocks in Europe were having a mixed day on Monday, with the FTSE 100 feeling the weight of a poor UK GDP reading, but the CAC 40 in Paris gaining as investors in France show confidence in President Emmanuel Macron - as he looks set to extend his time in office.

Read more
11 Apr 2022 11:17

Scancell shares soar as clinical trial opens for recruitment

(Alliance News) - Scancell Holdings PLC shares soared on Monday after the cancer immunotherapies developer said its phase 1/2 clinical trial with Modi-1 has opened for recruitment.

Read more
29 Mar 2022 19:21

IN BRIEF: Scancell broadens Covidity clinical trial in South Africa

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Updates on South African Health Products Regulatory Authority's approval of a protocol amendment to the phase 1 Covidity clinical trial being conducted at the University of Cape Town Lung Institute in South Africa.

Read more
17 Mar 2022 21:02

TRADING UPDATES: SimiGon merger to go ahead; Segro launches green bond

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Feb 2022 11:50

Image Scan sinks as it expects to post significant loss in first half

(Alliance News) - Image Scan Holdings PLC shares tanked on Tuesday after the company said it expects to post a significant loss for the first half of financial 2022 and thinks it is "unlikely" that the second half will fully recover the loss.

Read more
31 Jan 2022 22:07

TRADING UPDATES: MJ Hudson and Tandem see results ahead of views

TRADING UPDATES: MJ Hudson and Tandem see results ahead of views

Read more
26 Jan 2022 20:18

TRADING UPDATES: Somero upbeat after strong year; Scancell in profit

TRADING UPDATES: Somero upbeat after strong year; Scancell in profit

Read more
19 Jan 2022 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Nov 2021 13:49

Scancell treats first patient in melanoma tumour trial

(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell announced on Friday that the enrolment and treatment of the first patient had taken place in its multicentre phase 2 clinical trial of its 'SCIB1' tumour treatment at the Churchill Hospital in Oxford.

Read more
19 Nov 2021 11:37

IN BRIEF: Scancell starts SCIB1 phase 2 trial in UK after pause

IN BRIEF: Scancell starts SCIB1 phase 2 trial in UK after pause

Read more
16 Nov 2021 16:09

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
2 Nov 2021 15:20

DIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares

DIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares

Read more
1 Nov 2021 06:57

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

Read more
29 Oct 2021 20:28

TRADING UPDATES: Asia Dragon beats benchmark, Henderson Far East lags

TRADING UPDATES: Asia Dragon beats benchmark, Henderson Far East lags

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.